Pulmonary hypertension and obesity;Hypertension artérielle pulmonaire et obésité

Revue de Pneumologie Clinique

Volumn 58, Issue 2, 2002, Pages 104-110

  Sztrymf, B ^a   Ioos, V ^a   Sitbon, O ^a   Parent, F ^a   Simonneau, G ^a   Humbert, M ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Anorexic agents; Hypothyroidism; Hypoxemia; Obesity; Pulmonary hypertension; Sleep apnea; Thromboembolism

Indexed keywords

ANOREXIGENIC AGENT; FENFLURAMINE; AMINOREX; DRUG DERIVATIVE;

COMORBIDITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; HEART LEFT VENTRICLE FAILURE; HEMODYNAMICS; HYPERTENSION; HYPOTHYROIDISM; HYPOXEMIA; LUNG CIRCULATION; MORBIDITY; OBESITY; PULMONARY HYPERTENSION; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; THROMBOEMBOLISM; ANOXIA; HOSPITALIZATION; HUMAN; PATHOPHYSIOLOGY;

AMINOREX; ANOXIA; FENFLURAMINE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; HYPOTHYROIDISM; OBESITY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA SYNDROMES;

EID: 1842856379     PISSN: 07618417     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Pulmonary complications of obesity
2. Pulmonary physiologic changes of morbid obesity
3. Primary pulmonary hypertension
4. Pulmonary hypertension due to chronic hypoxic lung disease
5. Les hypertensions artérielles pulmonaires
6. Clinical classification of pulmonary hypertension
7. Obesity and cardiac function
8. Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss
9. Hemodynamic and respiratory changes in surgery of the morbidly obese
10. Pulmonary hypertension, "plexogenic pulmonary arteriopathy" and the appetite drugs aminorex: Post or proper?
11. Long-term follow-up of pulmonary hypertension in patients with and without anorectic drug intake
12. Dietary pulmonary hypertension
13. Pulmonary hypertension and fenfluramine
14. Primary pulmonary hypertension and fenfluramine use
15. Pulmonary hypertension and dexfenfluramine
16. Pulmonary hypertension and dexfenfluramine
17. Primary pulmonary hypertension with the use of fenfluramine derivates
18. Fatal pulmonary hypertension associated with short term use of fenfluramine and phentermine
19. Appetite suppressant drugs and the risk of primary pulmonary hypertension
20. Anorexigens and pulmonary hypertension in the United States
21. Slow and fast change in transmural pulmonary artery pressure in obstructive sleep apnoea
22. Cardiorespiratory consequences of sleep apnoea syndrome in patients with massive obesity
23. Pulmonary hypertension and hypoxemia in obstructive sleep apnoea syndrome
24. Pulmonary hypertension in the obstructive sleep apnoea syndrome: Prevalence, causes and therapeutic consequences
25. Sleep related breathing disorders and cadiovascular disease
26. Pulmonary hemodynamics in the obstructive sleep apnoea syndrome. Results in 220 consecutive patients
27. Pulmonary hypertension, hypoxemia and hypercapnia in obstructive sleep apnea patients
28. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients
29. Chronic thromboembolic pulmonary hypertension
30. Minor alterations in thyroid function tests associated with diabetes mellitus and obesity in outpatients without known thyroid illness
31. High prevalence of hypothyroidism in patients with primary pulmonary hypertension
32. Hypothyroidism and primary pulmonary hypertension: An auto-immune link?
33. HIV-associated primary pulmonary hypertension: A case control study
34. Hypothyroïdism and pulmonary hypertension: Observation and speculation
35. Autoimmune aspects of primary pulmonary hypertension
36. Tissue contents of endothelin vary according to thyroid hormon status in rats